"Sopharma" from Bulgaria gave offer for takeover of "Srbolek" – investments worth €20m

Bulgarian company "Sopharma", which gave offer for takeover of company "Srbolek", plans to invest about €80m in expansion of presence in the Balkans, €20m of which is to be invested in that Serbian pharmaceutircal company.

"Sopharma" has given the offer of takeover of at least 50% of stocks of Belgrade-based “Srbolek" by offering 910 CSD per stock where nominal value amounts to 420 CSD per stock.

Bulgarian pharmaceutical company has licensed all primary productions according to GMP standard ("good manufacture practice"), which is the base for entrance to EU’s market. Of seven factories that have GPM standard in Bulgaria, "Sopharma" owns five.

So far, none of the medicine manufacturers in Serbia meet GMP standard.

"Sopharma" is present in 33 countries in Europe, Asia, America and Australia and it employs more than 3,500 people and has 12 factories and 6 wholesale chains. The income from sale, in nine months of this year, for the entire group, amounted to about €128m, which is the increase of about €43m against the same period last year. (TANJUG)